UC San Diego Health Ranked No. 1 in San Diego, No. 20 in Nation for Cancer Care
|
For the first time in its history, UC San Diego Health made the U.S. News & World Report 2023–2024 “Best Hospitals National Honor Roll,” a distinction awarded to only 22 hospitals nationwide that are recognized for outstanding patient care. In addition, UC San Diego health was ranked No. 20 in the nation for its outstanding cancer care. Read More»
|
30th Annual Luau and Legends of Surfing Invitational
|
Join Moores on August 26 and 27, 2023 for a fundraiser like no other. Over its 30 year history, the Annual Luau has raised over $10 million to support novel cancer research and improve patient care. This year, an in-person sponsor party will take place on Saturday evening, followed by the Luau and Legends Invitational on Sunday morning. Tickets and volunteer opportunities still are available. Visit Website»
|
Caris Life Sciences Presentation: Overview of UCSD CodeAI at the Moores Cancer Center–A Special SFG Cross-Lab Meeting
|
UC San Diego recently signed the CODEai agreement, which allows its physicians and researchers access to the Caris Life Sciences CODEai research database to obtain preliminary data vis-a-vis specific research concepts. Please join an in-person (or via Zoom) information session to learn about accessing this valuable research tool. RSVP Here»
|
|
|
August 13–17, 2023
Palm Springs, CA
|
August 19, 2023 | 12:00 p.m. PT
Moores, Comer Commons
|
August 23, 2023 | 1:00 p.m. PT
|
August 31, September 6, and September 8, 2023 | 11:00 a.m. ET
Register by August 24, 2023
|
|
|
Applications for KL2 Mentored Career Development Award Now Open!
|
The ACTRI KL2 award is a mentored career development award that provides up to $120K toward salary, plus benefits, along with $25K per year in research funds. Successful applicants will receive up to 3 years of support. Applications are open through August 15, 2023.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
This award will fund up to $150,000 in November 2023 to support research on the early detection of ovarian cancer.
Deadline: Friday, September 1, 2023
|
This retention-focused, institutionally-supported program is intended to support under-represented minority faculty members in submitting successful resubmissions of NIH K or R grant applications (or equivalent). SUSTAIN aims to increase the likelihood of successful proposal resubmission by providing up to 1–2 years of protected time, grant writing training, and linkage to didactic, mentorship, and other resources customized to the applicant. SUSTAIN will provide 1–2 years of support at 50% of full-time salary (up to $60,000), which must be matched by the candidate's department and confirmed in a letter from the Department Chair. The combined effort must enable a total of at least 75% research effort.
Deadline: Friday, September 1, 2023
|
The BCRP Clinical Research Extension Award aims to (1) extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies and (2) increase the clinically relevant effect of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Patient contributions of tissue, serum, and other biologic specimens and their data are invaluable to saving lives. This BCRP mechanism ensures that science values those contributions with research that maximizes their effect.
Deadline: Tuesday, September 12, 2023
|
This Notice of Funding Opportunity (NOFO) invites proposals for research centers to advance cancer control equity by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health (SDOH) on adverse cancer control outcomes. Each Research Center will (1) develop interventions that target the multilevel pathways by which SDOH impact adverse cancer outcomes, (2) develop measures, methods, and assess community-level SDOH, community engagement, and cancer control equity processes and outcomes, and (3) build capacity and engagement among scholars from diverse backgrounds, those from groups underrepresented in the biomedical sciences, and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities.
Deadline: Thursday, September 14, 2023
|
|
|
Cell Metabolism
Alan R. Saltiel (Cancer Biology and Signaling)
|
Current Biology
Kevin D. Corbett (Cancer Biology and Signaling)
|
Cancer Research
Pablo Tamayo (Structural and Functional Genomics), Andrew M. Lowy (Solid Tumor Therapeutics), and Shweta Joshi (Solid Tumor Therapeutics)
|
|
|
VBI-1901-01: A Two-part, Phase I/IIA Dose-escalation Study to Define the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI1901 with Subsequent Extension of Optimal Dose in Recurrent GBM Subjects
|
XTX202-01/02-001: A First-in-human, Multicenter, Phase I/II, Open-label Study of XTX202 in Patients with Advanced Solid Tumors
|
ARV-471-mBC-102: A Phase Ib Trial of ARV471 in Combination with Everolimus in Patients with ER, HER2 Advanced, or Metastatic Breast Cancer
|
PI: Kay Yeung
NCT: NCT05501769
|
CB-LTSS: A Study to Evaluate Long-term Safety of CART Cell Therapy in Patients with Hematologic Malignancies
|
PI: Ayad Hamdan
NCT: NCT05332054
|
68284528MMY4006: Intermediate-size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Ciltacel) Out-of-specification (OOS) in Patients with Multiple Myeloma
|
PI: Caitlin Costello
NCT: NCT05346835
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Webinar: Starting HPV Vaccination at Age 9
Tuesday, August 8 | 12:00 p.m. to 1:00 p.m.
|
As a member of the California HPV Vaccination Roundtable, COE is proud to support this webinar, in recognition of CA HPV Vaccine Week (August 6–12, 2023). Please join COE for a presentation from American Cancer Society’s Dr. Debbie Saslow, Strategic Director of Screening and Vaccination, to learn about the importance of and supporting evidence for starting HPV vaccination at 9 years of age. In addition, the CA HPV Vaccination Roundtable will share an update on the current HPV vaccine data in California and review of our CA HPV Vaccine Week social media materials.
|
Prostate Cancer in the Black and African American Community: Barriers and Solutions
Tuesday, August 29 | 12:00 p.m. to 1:00 p.m.
|
African American men exhibit an increased risk for developing prostate cancer, compared to white men and other men of color. Not only will one in six Black men will develop prostate cancer in his lifetime, but Black men also are 1.7 times more likely to be diagnosed with—and 2.1 times more likely to die from—prostate cancer than white men. Moreover, Black men are more likely than white men to be diagnosed with advanced disease. Against this backdrop, please join ZERO Prostate Cancer and COE virtually on August 29, 2023 to discuss barriers and solutions to prevent, find, treat, and survive prostate cancer in the Black and African American community. Members of the community, advocates, and practitioners all are welcome.
|
Free Immunization Clinic at Copley YMCA
Saturday, August 12 | 10:00 a.m. to 2:00 p.m.
|
In recognition of California HPV Vaccine Week 2023, COE will staff a table with HPV information at the monthly Free Immunization Clinics, hosted by the Copley YMCA and Champions for Health, which will provide immunization clinics for flu, COVID-19, and HPV (supplies are limited for HPV). All clinics are free, open to the community, and no registration is required. Walk-ups are encouraged.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to sjchristie@ucsd.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
